A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Avonex 15 Year Long Term Follow-up Study
- Status
- COMPLETED
- Phase
- N/A
BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
- Status
- TERMINATED
- Phase
- PHASE2
Natalizumab High Titer Immunogenicity and Safety
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2
Tysabri Observational Program
- Status
- COMPLETED
- Phase
- N/A
Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
- Status
- COMPLETED
- Phase
- PHASE4
Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
GER-009-06-AVX Early Therapy in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
- Status
- COMPLETED
- Phase
- PHASE4
GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
- Status
- TERMINATED
- Phase
- PHASE2
TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World
- Status
- COMPLETED
- Phase
- N/A
TYSABRI Global Observational Program in Safety
- Status
- COMPLETED
- Phase
- N/A
Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor
- Status
- WITHDRAWN
- Phase
- PHASE1